A carregar...

Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis

BACKGROUND: Oral 5‐aminosalicylic acid (5‐ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. Previously, it was found that 5‐ASA drugs in doses of at least 2 g/day, were more effective than placebo but no more effective th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Wang, Yongjun, Parker, Claire E, Bhanji, Tania, Feagan, Brian G, MacDonald, John K
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2016
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7045743/
https://ncbi.nlm.nih.gov/pubmed/27101467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000543.pub4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!